Related references
Note: Only part of the references are listed.HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling
Yaqun Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
The role of exosomes and miRNAs in drug-resistance of cancer cells
Duc-Hiep Bach et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway
Yiwei Liao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma
Yuanyuan Gan et al.
TUMOR BIOLOGY (2017)
Phytol induces ROS mediated apoptosis by induction of caspase 9 and 3 through activation of TRAIL, FAS and TNF receptors and inhibits tumor progression factor Glucose 6 phosphate dehydrogenase in lung carcinoma cell line (A549)
Parth Thakor et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin
Yeqian Feng et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Hypoxia Responsive, Tumor Penetrating Lipid Nanoparticles for Delivery of Chemotherapeutics to Pancreatic Cancer Cell Spheroids
Prajakta Kulkarni et al.
BIOCONJUGATE CHEMISTRY (2016)
Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells
Yunjie Cao et al.
MOLECULAR MEDICINE REPORTS (2016)
Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer
Xuezhi He et al.
TUMOR BIOLOGY (2016)
Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells
Nianli Liu et al.
FEBS LETTERS (2015)
Therapeutic applications of TRAIL receptor agonists in cancer and beyond
Gustavo P. Amarante-Mendes et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Hepatocellular carcinoma: A comprehensive review
Lisa P. Waller et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
bta-miR-29b attenuates apoptosis by directly targeting caspase-7 and NAIF1 and suppresses bovine viral diarrhea virus replication in MDBK cells
Qiang Fu et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2014)
An emerging understanding of long noncoding RNAs in kidney cancer
Shuigen Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
The multilayered complexity of ceRNA crosstalk and competition
Yvonne Tay et al.
NATURE (2014)
Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells
T. Lu et al.
CANCER GENE THERAPY (2013)
Function of miRNA in Controlling Drug Resistance of Human Cancers
Liu Hong et al.
CURRENT DRUG TARGETS (2013)
miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2
Tao Song et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma
Nataliya Razumilava et al.
HEPATOLOGY (2012)
Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?
Andrew X. Zhu
ANNALS OF SURGICAL ONCOLOGY (2010)
MiRNAs as biomarkers and therapeutic targets in cancer
Helen M. Heneghan et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Micromarkers: miRNAs in cancer diagnosis and prognosis
Manuela Ferracin et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
Evolution and Functions of Long Noncoding RNAs
Chris P. Ponting et al.
CELL (2009)
Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
Kuen-Feng Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
F. Fornari et al.
ONCOGENE (2008)
TRAIL signalling: Decisions between life and death
Christina Falschlehner et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis
ZY Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hepatocellular carcinoma: Current management and future trends
BI Carr
GASTROENTEROLOGY (2004)
A unified model for apical caspase activation
KM Boatright et al.
MOLECULAR CELL (2003)
Apo2L/TRAIL and its death and decoy receptors
HN LeBlanc et al.
CELL DEATH AND DIFFERENTIATION (2003)
Hepatocellular carcinoma - Systemic treatments
M Di Maio et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
A Ashkenazi
NATURE REVIEWS CANCER (2002)
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
MR Sprick et al.
IMMUNITY (2000)
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
FC Kischkel et al.
IMMUNITY (2000)
Hepatobiliary surgery
H Bismuth et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
